Avexxin
Latest round
- Series B
Last raised
- Nov 2012
Total raised
- Undisclosed
Investors
- 2
About Avexxin
Avexxin is based in Norway and operates as a pharmaceutical firm which engages in research and development of small molecule therapeutics for patients with chronic inflammatory conditions.
Who invested in Avexxin
2 investors across 3 rounds
See all investors in Avexxin
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Avexxin
Who invested in Avexxin?
Avexxin has 2 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avexxin raised?
Avexxin has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Avexxin last raise money?
Avexxin's most recent round on record is a Series B, in Nov 2012.
What does Avexxin do?
Avexxin is based in Norway and operates as a pharmaceutical firm which engages in research and development of small molecule therapeutics for patients with chronic inflammatory conditions.
Where is Avexxin headquartered?
Avexxin is headquartered in Trondheim, Norway.
Which VCs invest in companies like Avexxin?
Among active investors with capital left to deploy, Index Ventures, Forbion, Balderton Capital and Sofinnova Partners back healthcare companies at Avexxin's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like Avexxin? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.